These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7407796)

  • 1. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician.
    Hoogstraten B
    Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations.
    Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion II: Critical definitions and criteria for evaluation.
    Cancer Treat Rep; 1980; 64(2-3):469-71. PubMed ID: 7407786
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion III: Designs to optimize combined-modality therapy and selection and verification of prognostic factors.
    Cancer Treat Rep; 1980; 64(2-3):497-8. PubMed ID: 7407789
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the Symposium on Designs for Clinical Cancer Research. Summary views: A statistician's perspective.
    Cox DR
    Cancer Treat Rep; 1980; 64(2-3):533-5. PubMed ID: 7407795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subject-own-control designs from a statistical perspective.
    Fleiss JL
    Psychopharmacol Bull; 1979 Jul; 15(3):42-4. PubMed ID: 493461
    [No Abstract]   [Full Text] [Related]  

  • 7. [The decision-making value of clinical studies].
    Sámal M; Rezný Z; Maríková E; Foltýnová V; Dienstbier Z
    Cas Lek Cesk; 1983 Mar; 122(12):374-7. PubMed ID: 6861173
    [No Abstract]   [Full Text] [Related]  

  • 8. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized clinical trials and research strategy.
    Simon R
    Cancer Treat Rep; 1982 May; 66(5):1083-7. PubMed ID: 7083212
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices.
    Goode J; Sapirstein W; Zuckerman B
    Catheter Cardiovasc Interv; 2007 May; 69(6):920-1. PubMed ID: 17455345
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the alternative methods of calculating survival curves arising from clinical trials.
    Sylvester RJ; Machin D; Staquet MJ
    Biomedicine; 1978 Sep; 28 Spec No():49-53. PubMed ID: 363196
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on the National Cancer Institute's clinical trials cooperative group program.
    Wallner PE
    J Am Coll Radiol; 2004 Nov; 1(11):865-6. PubMed ID: 17411719
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biostatistics in cancer clinical trials].
    Ohashi Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):241-52. PubMed ID: 9480646
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performing serial testing of treatment effects.
    Fleming TR; Green SJ; Harrington DP
    Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials: what you and your patients need to know.
    Yoder LH
    Medsurg Nurs; 2005 Oct; 14(5):351-3; quiz 354. PubMed ID: 16318119
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.